The Equity Engine.
The UK patient experience data platform for regulated healthcare.
The Equity Engine captures how people actually live with a condition, use a device, or receive a treatment, from a 6,000-strong UK panel recruited through community partners, and turns that data into the specific evidence artefact a regulator, HTA body, NHS procurement team, or NIHR grant reviewer is now asking for.
Participants, community partners, and the analytical platform that turns the data into a submission-ready file.
Every participant is recruited through a UK community partner and completes a Social Determinants of Health profile at sign-up. Every downstream output can therefore be stratified by the subgroups regulators, HTA bodies and NHS procurement now ask about.
Charities, faith organisations, disease-specific groups and health-innovation networks who co-design outputs and stay engaged across projects. Not drop-in, drop-out recruitment. Every partner signs a memorandum of understanding, receives a share of sponsor engagement fees, and holds veto power on any output that identifies their community. This is why our sample over-indexes on the exact populations pivotal trials systematically miss.
Traditional research designs miss most of what people actually experience. We capture across modalities: video diaries, voice notes, longitudinal surveys, focus groups, patient councils and lived-experience narratives. Every modality is analysed and synthesised by our AI pipeline into evidence files pre-formatted for the specific framework you are submitting to. No re-formatting, no bespoke deliverables, no scope creep.
Not a digital panel. Not a CRO. Not an eCOA platform.
You can hire a digital-first panel provider to send you people. You can hire a CRO to enrol them at sites. You can hire an eCOA vendor to collect data on them. None of them produce the subgroup and lived-experience evidence a regulator, HTA body or NHS procurement team now asks about first.
| Digital panel providers | Traditional recruitment CROs | eCOA / ePRO platforms | The Equity Engine | |
|---|---|---|---|---|
| Sampling frame | Digital-first panel aggregation | Site-based, opportunistic | Sponsor-provided | Community-partner MOUs; over-indexed on populations pivotal trials miss |
| Subgroup evidence | Not produced | Not produced | Not produced | Produced by default, stratified by 8 social factors |
| Submission-ready outputs | No | No | Data only | Pre-formatted for JCA, ESF, DTAC, PMS, INCLUDE |
| Pricing | Per-recruit variable | Time-and-materials | Per-trial licence | Fixed scope, fixed price, fixed duration |
| Community accountability | None | None | None | Community-partner veto on output release; revenue share |
One platform, three buyers, six fixed-price engagements.
Pharma & biotech
For pharma medical-affairs, market-access and HEOR teams running a JCA or NICE submission, planning a PMCF, or standing up a patient council.
Medical devices & digital health
For SaMD, digital-health and medical-device manufacturers preparing for NHS procurement, NICE ESF, DTAC or defending a live approval.
Academic, NIHR & non-profit
For academic Principal Investigators writing grants or running NIHR-funded studies that must satisfy INCLUDE. Non-profit access is free by application.
The layer regulators, buyers and community partners all inspect first.
Consented at every stage
Every participant re-consents on a use-case-specific schema, at NIHR guide rates.
Community-partnered
Recruited through named community organisations under signed MOU. Not through a digital panel aggregator.
Independently governed
Trust & Ethics Board: lay chair, clinical ethicist, DPO, two community-partner representatives with veto over any identifying output.
UK-anchored
Data stays in UK jurisdiction. Every output auditable to raw response level.
Not sure which engagement you need?
Take the Regulatory Readiness Scorecard. Twenty questions, six domains, a plain-English diagnosis of the regulatory clauses you are exposed under, and the specific fixed-price engagement that closes each gap.